Skip to main content
. Author manuscript; available in PMC: 2021 Sep 1.
Published in final edited form as: Arthritis Care Res (Hoboken). 2020 Sep;72(9):1296–1304. doi: 10.1002/acr.24117

Figure 3. Longitudinal analysis of outcome measures in patients experiencing a change in clinical disease activity from remission to active disease.

Figure 3.

(A) Patient reported outcomes, (B) Laboratory Outcomes, and (C) Imaging Outcome. Data is plotted as median and interquartile range and n=8–11. Wilcoxon signed rank test was used to compare outcome measure scores between remission and active visits. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001, n.s.=not significant. PtGlobal= Patient global assessment; MFI= Multi-dimensional fatigue inventory; SF-36 MCS= 36-item short form health survey mental component summary score; SF-36 PCS= 36-item short form health survey physical component summary score; BIPQ= brief illness perception questionnaire; ESR= erythrocyte sedimentation rate; CRP= c-reactive protein; PETVAS= qualitative score of vascular FDG-PET activity.